Lack of involvement of 4-hydroxynorephedrine in phenylpropanolamine-induced anorexia in rats.
The anorexic effects of phenylpropanolamine (PPA) appear to be qualitatively different in humans and rats. One factor that may account for these differences is that PPA is excreted essentially unchanged in humans, while nearly 30% is metabolized into 4-hydroxynorephedrine (4-OHN) in rats. To investigate the contribution of 4-OHN to the anorexic properties of PPA, this experiment compared the effects of equal doses (0.0-20.0 mg/kg, IP) of both drugs on eating and drinking during restricted feeding trials in the same group of food-deprived, female rats. Both 15.0 and 20.0 mg/kg of PPA significantly decreased eating when compared to saline vehicle, while 5.0-20.0 mg/kg of the drug reduced prandial drinking. In comparison, only the highest dose of 4-OHN (20.0 mg/kg) significantly suppressed food and water intake. When the percentage of reduction produced by corresponding doses of the two drugs was compared, PPA proved to be more than twice as potent as 4-OHN. It is concluded that, at the doses used, 4-OHN is unlikely to significantly contribute to reductions in deprivation-induced eating produced by the acute administration of PPA.
Rushing
P A
PA
Department of Psychology, Memphis State University, TN 38152.
Mittleman
G
G
D000818:Animals; D001066:Appetite / Q000187:drug effects* / Q000502:physiology; D001711:Biotransformation; D004305:Dose-Response Relationship, Drug; D004326:Drinking / Q000187:drug effects / Q000502:physiology; D004435:Eating / Q000187:drug effects* / Q000502:physiology; D005260:Female; D010665:Phenylpropanolamine / Q000493:pharmacokinetics / Q000494:pharmacology*; D051381:Rats; D010137:p-Hydroxynorephedrine / Q000493:pharmacokinetics / Q000494:pharmacology*
D010665:Phenylpropanolamine; D010137:p-Hydroxynorephedrine